Tammy Terry
Family · Wytheville, VANPI 1376711721
Payments from drug & device makers
Across 127 payments — averaging $15.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$382
- Novo Nordisk$221
- Takeda Pharmaceuticals U.S.A., Inc.$169
- Atricure, Inc.$144
- Novartis$138
- Abbott$119
- plus $750 from 17 others
What the payments were for
- Food & beverage$1,924100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 35 | $382 |
| Novo Nordisk | 22 | $221 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $169 |
| Atricure, Inc. | 1 | $144 |
| Novartis | 9 | $138 |
| Abbott | 7 | $119 |
| Biohaven Pharmaceuticals, Inc. | 5 | $117 |
| Lilly USA, LLC | 6 | $107 |
| Amgen(2 entities) | 6 | $91 |
| AstraZeneca | 5 | $70 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $47 |
| Ironshore Pharmaceuticals Inc. | 2 | $46 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $41 |
| Boehringer Ingelheim | 2 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $33 |
| Pfizer | 2 | $28 |
| GSK | 2 | $28 |
| Corium, LLC | 1 | $23 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Merck | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,924 in reported general payments places this provider in the 80th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 14 | $2,660 |
| Lidocaine | 20 | $1,634 |
| Diclofenac Sodium | 21 | $1,135 |
| Ondansetron OdtOndansetron | 30 | $783 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $660 |
| Levocetirizine Dihydrochloride | 26 | $280 |
| Famotidine | 19 | $242 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $236 |
| Hydroxyzine Hcl | 21 | $207 |
| Nystatin | 12 | $165 |
| Amlodipine Besylate | 21 | $142 |
| Buspirone Hcl | 12 | $142 |
| Montelukast Sodium | 25 | $135 |
| Pantoprazole Sodium | 22 | $128 |
| Lisinopril | 17 | $95 |
Paid to pharmacies, not to this prescriber.
Other family in Wytheville
- Susan MooreWytheville$438K
- Tara ParksWytheville$13K
- Andrea CottonVirginia Beach$696K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
- Adam MedlinHampton$67K
- Casey SharpDanville$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.